These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1969581)

  • 21. A newborn with Down syndrome-transient myeloproliferative disorder.
    Akdag A; Tunç B; Oğuz S; Dilli D; Dilmen U
    J Perinat Med; 2010 Jul; 38(4):445-7. PubMed ID: 20443668
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemotherapy for transient myeloproliferative disorder in a premature infant with Down syndrome.
    Oztekin O; Kalay S; Tezel G; Tayfun F; Kupesiz A; Hangul M; Akcakus M; Oygur N
    J Clin Pharm Ther; 2013 Jun; 38(3):262-4. PubMed ID: 23510328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
    Zipursky A; Brown EJ; Christensen H; Doyle J
    Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transient myeloproliferative disorder in a neonate with Down syndrome.
    Raney RB
    Clin Pediatr (Phila); 1990 Sep; 29(9):547. PubMed ID: 2146998
    [No Abstract]   [Full Text] [Related]  

  • 25. Vesiculopustular eruption in a neonate with trisomy 21 syndrome as a clue of transient myeloproliferative disorders.
    Piersigilli F; Diociaiuti A; Boldrini R; Auriti C; Curci M; El Hachem M; Seganti G
    Cutis; 2010 Jun; 85(6):286-8. PubMed ID: 20666188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Megakaryoblastic disorders in children.
    Lorsbach RB
    Am J Clin Pathol; 2004 Dec; 122 Suppl():S33-46. PubMed ID: 15690641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Megakaryocyte proliferative disorder in neonates with Down's syndrome.
    Koide R; Takahashi H; Tsunematsu Y; Sasaki M; Sugita K; Nakazawa S; Enomoto Y; Watanabe Y; Kaneko Y
    Keio J Med; 1987 Jan; 36(1):57-61. PubMed ID: 2956448
    [No Abstract]   [Full Text] [Related]  

  • 28. Are trisomy 21 fetuses subject to a myeloproliferation which is manifest in the maternal blood?
    Fisher AM
    Prenat Diagn; 1997 Sep; 17(9):885-6. PubMed ID: 9316139
    [No Abstract]   [Full Text] [Related]  

  • 29. Transient myeloproliferative disorder and non-immune hydrops fetalis in a neonate with trisomy 21.
    Hon KL; Leung TY
    Hong Kong Med J; 2014 Feb; 20(1):78.e3-e4. PubMed ID: 24473698
    [No Abstract]   [Full Text] [Related]  

  • 30. Vesiculopustular eruptions in Down syndrome neonates with myeloproliferative disorders.
    Nijhawan A; Baselga E; Gonzalez-Ensenat MA; Vicente A; Southern JF; Camitta BM; Esterly NB; Drolet BA
    Arch Dermatol; 2001 Jun; 137(6):760-3. PubMed ID: 11405767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis.
    Karandikar NJ; Aquino DB; McKenna RW; Kroft SH
    Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-2003. A five-day-old girl with leukocytosis and a worsening rash from birth.
    Wolfe LC; Weinstein HJ; Ferry JA
    N Engl J Med; 2003 Jun; 348(25):2557-66. PubMed ID: 12815142
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trisomy 21, fetal hydrops, and anemia: prenatal diagnosis of transient myeloproliferative disorder?
    Hendricks SK; Sorensen TK; Baker ER
    Obstet Gynecol; 1993 Oct; 82(4 Pt 2 Suppl):703-5. PubMed ID: 8378020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient myeloproliferative disorder in Down's syndrome.
    Kshirsagar VY; Ahmed M; Colaco SM; Ahmed M
    Indian J Pathol Microbiol; 2012; 55(3):426-7. PubMed ID: 23032858
    [No Abstract]   [Full Text] [Related]  

  • 36. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
    Roy A; Roberts I; Vyas P
    Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Test and teach. Number Seventy. Diagnosis: Transient myeloproliferative disorder in a child with Down's syndrome.
    Wright SJ; Kerwick AM; Rodwell RL; Taylor KM
    Pathology; 1993 Apr; 25(2):133, 207-8. PubMed ID: 8367191
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
    Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
    J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid proliferation in a newborn with Down syndrome.
    Agnihotri M; Khatib Y; Gujral S
    Indian J Cancer; 2010; 47(4):470-1. PubMed ID: 21131764
    [No Abstract]   [Full Text] [Related]  

  • 40. Transient abnormal myelopoeisis in newborns with Down syndrome.
    Zarina AL; Hamidah A; Yong SC; Rohana J; Hamidah NH; Azma RZ; Boo NY; Jamal R
    Malays J Pathol; 2007 Dec; 29(2):107-11. PubMed ID: 19108403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.